overcoming the challenges faced in identifying novel targets for adc development
Published 1 year ago • 39 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:15
jk06, a biparatopic adc in preclinical development
-
24:48
challenges and advances in antibody-drug conjugates.
-
38:07
antibody-drug conjugates (adcs): current research and overcoming challenges - webinar playback
-
8:27
the ncounter antibody-drug conjugate panel answers key questions throughout the development process
-
16:46
what are antibody drug conjugates (adcs)? 👀 the newest cancer treatment breakthrough – explained!
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
3:23
antibody-drug conjugates in the treatment of solid tumors
-
17:52
how can broadening knowledge in bioconjugate design & development help treat oncology & beyond?
-
17:47
biomissiles adc drugs
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
walk in patient with allergic eye disease
-
40:35
antibody drug development challenges & solutions
-
43:25
safety considerations for the development of antibody drug conjugates
-
54:24
model-based strategy to guide the choice of clinical doses for antibody–drug conjugates
-
55:24
challenges in drug development for als
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc
-
47:58
overcome the multiple challenges of neutralizing antibodies in cancer therapy using phage display
-
1:24
adcs in lung cancer treatment
-
0:44
adcs in early breast cancer